These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2126024

  • 1. [Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
    Nakamura Y, Yoshimura Y, Yamada H, Maruyama K, Nanno T, Ubukata Y, Ando M, Takahashi K, Suzuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1620-6. PubMed ID: 2126024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical usefulness of GnRH agonist therapy for premenopausal women with uterine leiomyoma].
    Kurose T, Hando T, Shiota A.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):35-41. PubMed ID: 7844451
    [Abstract] [Full Text] [Related]

  • 4. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.
    Imai A, Sugiyama M, Furui T, Tamaya T.
    J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Nakamura Y, Yoshimura Y.
    Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612
    [No Abstract] [Full Text] [Related]

  • 9. Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
    Rolland R, Franssen AM, Willemsen WN, Corbey RS.
    Prog Clin Biol Res; 1986 Sep; 225():313-20. PubMed ID: 3097670
    [No Abstract] [Full Text] [Related]

  • 10. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R, Gesenhues T, Deichert U, Duda V, Sturm G, Schulz KD.
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata.
    Franssen AM, Willemsen WN, Corbey RS, Doesburg WH, van 't Veen AJ, Rolland R.
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul 25; 40(3):221-8. PubMed ID: 1908799
    [Abstract] [Full Text] [Related]

  • 12. Differential reduction in the volume of leiomyoma and uterus during buserelin treatment.
    Puzigaća Z, Prelević GM, Sretenović Z.
    Gynecol Endocrinol; 1994 Mar 25; 8(1):39-43. PubMed ID: 8059616
    [Abstract] [Full Text] [Related]

  • 13. Conservative management for perimenopausal women with uterine leiomyomas using Chinese herbal medicines and synthetic analogs of gonadotropin-releasing hormone.
    Sakamoto S, Mitamura T, Iwasawa M, Kitsunai H, Shindou K, Yagishita Y, Zhou YF, Sassa S.
    In Vivo; 1998 Mar 25; 12(3):333-7. PubMed ID: 9706480
    [Abstract] [Full Text] [Related]

  • 14. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH.
    Fertil Steril; 2010 Jan 25; 93(1):192-8. PubMed ID: 19135657
    [Abstract] [Full Text] [Related]

  • 15. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
    Hilário SG, Bozzini N, Borsari R, Baracat EC.
    Fertil Steril; 2009 Jan 25; 91(1):240-3. PubMed ID: 18249392
    [Abstract] [Full Text] [Related]

  • 16. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
    Shaw RW, Matta W.
    Clin Reprod Fertil; 1986 Oct 25; 4(5):329-36. PubMed ID: 3100012
    [Abstract] [Full Text] [Related]

  • 17. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
    Donnez J, Schrurs B, Gillerot S, Sandow J, Clerckx F.
    Fertil Steril; 1989 Jun 25; 51(6):947-50. PubMed ID: 2498131
    [Abstract] [Full Text] [Related]

  • 18. Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma.
    Maheux R, Lemay A, Turcot-Lemay L.
    Am J Obstet Gynecol; 1988 Feb 25; 158(2):361-4. PubMed ID: 3124621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.